Clinical Trials in Salt Lake City

Showing 8261-8280 of 16,694 trials

Exploring the Role of Neuroactive Steroids in Tourette Syndrome

NCT05281445

Tourette syndrome (TS) is a disabling neurodevelopmental disorder characterized by motor and phonic tics. The studies proposed in this application will explore the endocrine mechanisms underlying two of the least well-understood biological characteristics of TS, namely its marked male predominance and stress susceptibility. In particular, our exploratory studies will characterize the steroid profile in TS-affected boys and girls to identify novel potential biomarkers and therapeutic targets for this disorder.

Tourette Syndrome in Children

University of Utah120 participantsStarted Apr 2022

Salt Lake City, Utah, United States

COMPLETEDPhase 3< 1 mile

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults

NCT01231516

ING111762 is a 48 week, randomized, double-blind, active-controlled, multicenter, parallel group, non-inferiority study. The study will be conducted in at least 688 HIV-1 infected antiretroviral experienced, integrase-naïve subjects. Subjects will be randomized 1:1 to receive GSK1349572 50 mg once daily or raltegravir (RAL) 400 mg twice daily, each added to an investigator selected background regimen consisting of at least one fully active agent plus no more than one second single agent which may or may not be active. Antiviral activity, safety, pharmacokinetics (PK), and development of viral resistance will be evaluated.

Infection, Human Immunodeficiency VirusHIV Infections

ViiV Healthcare724 participantsStarted Oct 2010

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +177 more locations

Exploring the Role of Neuroactive Steroids in Tourette Syndrome

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults

Find Trials by Condition in Salt Lake City

Adaptive COVID-19 Treatment Trial 2 (ACTT-2)

Asprin Dosing Estimator in Healthy Adults

Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy

Study of Intravenous and Subcutaneous Administration of Risankizumab in Healthy Participants

A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Adaptive COVID-19 Treatment Trial (ACTT)

A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo

Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD

A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.

A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis

Non Exudative AMD Imaged With SS-OCT- Extension

Non Exudative AMD Imaged With SS-OCT

Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care

Phase 1, Dose-Escalation Study of IGN002 in NHL Subjects

HTX-011 Administration Study in Planned Caesarean Section Procedure

Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children